Lancet Infect Dis. 2018 Mar;18(3):308–17. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. PubMed PMID: 29229440.
20. Dubourg G., Raoult D. The challenges of preexposure prophylaxis for bacterial sexually transmitted infections. Clin Microbiol Infect. 2016 Sep;22(9):753–56. doi: 10.1016/j.cmi.2016.08.022. Epub 2016 Aug 29. Review. PubMed PMID: 27585939.
21. Fairley C.K., Chow EPF. Doxycycline postexposure prophylaxis: let the debate begin. Lancet Infect Dis. 2018 Mar;18(3):233–4.
22. Spinelli M. A., Scott H. M., Vittinghoff E., Liu A. Y., Coleman K., Buchbinder S. P. High interest in doxycycline for sexually transmitted infection postexposure prophylaxis in a multicity survey of men who have sex with men using a social networking application. Sex Transm Dis. 2019 Apr;46(4):e32–4.
23. Hook E. W. 3rd. 2008 Thomas Parran Award lecture. Translational research, STD control, and health disparities: a challenge and an opportunity. Sex Transm Dis. 2008 Dec;35(12):969–72.
24. Centers for Disease Control and Prevention. A Public Health Approach for Advancing Sexual Health in the United States: Rationale and Options for Implementation, Meeting Report of an External Consultation. Atlanta, GA: Centers for Disease Control and Prevention.